Hyperfine Reports Strong Q4 Revenue Growth, Secures $40M Debt Facility, Extends Cash Runway into 2028
summarizeSummary
Hyperfine, Inc. announced Q4 2025 financial results with 128% revenue growth, provided 2026 guidance projecting 55% revenue growth, and secured a $40 million debt facility, extending its cash runway into 2028.
check_boxKey Events
-
Strong Q4 2025 Revenue Growth
Revenues for the fourth quarter of 2025 increased 128% to $5.29 million, compared to $2.32 million in the fourth quarter of 2024.
-
Positive 2026 Financial Guidance
Management expects full-year 2026 revenue to be approximately $20 to $22 million, representing 55% growth at the midpoint, and cash burn to decline by 10% to $26 to $28 million.
-
Secured $40 Million Debt Facility
The company secured a $40 million senior secured term loan facility in March 2026, with an initial funding of $15 million and an additional $25 million available upon achieving commercial milestones.
-
Extended Cash Runway
Including recent equity financing of over $20 million in October 2025 and the initial debt tranche, the company has bolstered its balance sheet with an expected cash runway into 2028.
auto_awesomeAnalysis
Hyperfine, Inc. reported strong fourth-quarter revenue growth and provided optimistic guidance for 2026, projecting 55% revenue growth and a 10% reduction in cash burn. Critically, the company bolstered its balance sheet by securing a $40 million senior secured term loan facility and raising over $20 million in equity in late 2025, extending its cash runway into 2028. This significant capital infusion addresses liquidity concerns and provides the necessary funding for commercial expansion and continued product development, including recent FDA clearance for stroke detection software.
At the time of this filing, HYPR was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $123.4M. The 52-week trading range was $0.53 to $2.22. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.